Abstract No. 56 Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells with and Without Hyaluronic Acid for Treatment of Chronic Low Back Pain: A Prospective, Randomized, Double-Blind, Concurrent-Controlled 36-Month Study
20260 citationsJournal Article
Field-Weighted Citation Impact: 0.00
Abstract No. 56 Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells with and Without Hyaluronic Acid for Treatment of Chronic Low Back Pain: A Prospective, Randomized, Double-Blind, Concurrent-Controlled 36-Month Study | Researchclopedia